- $46.35m
- $422.64m
- $401.98m
- 53
- 78
- 13
- 46
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 292 | 367 | 470 | 515 | 402 |
Cost of Revenue | |||||
Gross Profit | 213 | 260 | 313 | 330 | 259 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 379 | 456 | 563 | 737 | 513 |
Operating Profit | -87 | -89.5 | -93.3 | -222 | -111 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -93.2 | -105 | -127 | -224 | -96.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -96.1 | -108 | -125 | -226 | -100 |
Net Income Before Extraordinary Items | |||||
Net Income | -96.1 | -108 | -125 | -226 | -100 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -96.1 | -108 | -125 | -226 | -100 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.43 | -1.41 | -1.68 | -2.74 | -1.07 |